NASDAQ · Unclassified100% Authentic Upstream Feed (MR-007)

Regeneron Pharmaceuticals Inc (REGN)

Real-time institutional stock price, dual quantitative model evaluation (4-Factor Quant Rank + 6-Factor Fundamental Composite), valuation multiples, and forensic accounting audit.

Live Authentic Market Price
$941.00
+$24.94 (+2.72%)
Vol: 468,670
Market Capitalization$97.34B
P/E Multiple (TTM)19.75
52-Week Range$591.52 – $991.73
Beta / Volatility0.10
Model A · Equal-Weight 25%

4-Factor Quant Rank

#971
Percentile Score:57.7 / 100
Valuation Percentile:63.7
Growth Percentile:54.4
Business Quality Percentile:77.5
Momentum Percentile:35.2
Cross-sectional universe comparison across 2,714 U.S. equities (Official v2.1).
Model B · Fundamental Pillars

6-Factor Fundamental Rating

A
Fundamental Score:Partial
80/100
Valuation:A+
Growth:A
Profitability:A
Financial Health:—
EPS Revisions:—
Dividend Quality:B-
Absolute balance sheet health and SEC Edgar filing verification.

Source-Backed Financial Highlights

SEC EDGAR & Market Data Lineage
Revenue (TTM)$14.34B
Diluted EPS$45.28
Forward P/E13.76
Price to Sales5.63
Operating Margin2879.0%
Net Margin2851.0%

Institutional Peer Comparison Cohort

Direct sector comparables for Regeneron Pharmaceuticals Inc in Unclassified

4-Factor Quant Benchmarks
VRTXVRTX Common Stock
Compare→
GILDGILD Common Stock
Compare→
BIIBBIIB Common Stock
Compare→
AMGNAMGN Common Stock
Compare→